Clinical Trial Update: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind trial evaluating NRCT-101SR in combination with NRCT-202XR versus NRCT-202XR alone for attention-deficit/hyperactivity disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• NRCT-101SR
• NRCT-202XR

Snippet

Sponsor: Neurocentria, Inc. | Conditions: ADHD | Phase 2 | Status: TERMINATED